CORRESP Filing
SELLAS Life Sciences Group, Inc.
Date: Nov. 21, 2025 · CIK: 0001390478 · Accession: 0001104659-25-114977
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-290829
Letter
Via EDGAR United States Securities and Exchange Commission Division of Corporate Finance Registration Statement on Form S-3 Filed October 10, 2025 File No. 333-290829 Acceleration Request
Dear Mr. Campbell,
Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the "Registrant") hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-290829), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on Tuesday, November 25, 2025, or as soon thereafter as practicable.
Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement.
Very truly yours,
SELLAS Life Sciences Group, Inc.
Show Raw Text
CORRESP 1 filename1.htm SELLAS Life Sciences Group, Inc. 7 Times Square, Suite 2503 New York, New York 10036 November 21, 2025 Via EDGAR Alan Campbell United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: SELLAS Life Sciences Group, Inc. Registration Statement on Form S-3 Filed October 10, 2025 File No. 333-290829 Acceleration Request Dear Mr. Campbell, Pursuant to Rule 461 of Regulation C promulgated under the Securities Act of 1933, as amended, SELLAS Life Sciences Group, Inc. (the "Registrant") hereby respectfully requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-290829), so that it may become effective at 5:00 p.m. (Washington, D.C. time) on Tuesday, November 25, 2025, or as soon thereafter as practicable. Please call Daniel A. Bagliebter, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., counsel to the Registrant, at (212) 692-6856 with any comments or questions regarding the Registration Statement. Very truly yours, SELLAS Life Sciences Group, Inc. /s/ Angelos M. Stergiou, M.D., Sc.D., h.c. By: Angelos M. Stergiou, M.D., Sc.D., h.c. Its: President and Chief Executive Officer cc: Stacy E. Yeung, Esq., SELLAS Life Sciences Group, Inc. Daniel A. Bagliebter, Esq., Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.